An edition of FDA integrity issues (1996)
FDA integrity issues
hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on VISX, Inc. document disclosure, July 31, 1996.
By United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
Publish Date
1996
Publisher
U.S. G.P.O.,For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Language
eng
Pages
83
Description:
subjects: Corrupt practices, Criminal investigation, Inc VISX, Medical laser industry, Trials, litigation, United States, United States. Food and Drug Administration, Management, Officials and employees, Medical instruments and apparatus, Marketing, Certification, Fraud investigation
Places: United States